Mentor Capital Inc. (MNTR) 3.4700 $MNTR Mentor Capital

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mentor Capital Inc. (MNTR) 3.4700 $MNTR

Mentor Capital Targets $100 Million for Marijuana Investments from Call of Series D Warrants
Business Wire - Wed Mar 12, 11:49AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it is Calling its 15 Million Series D ($7) warrants at their long-standing strike price of $7.00 per share, and in this fashion targets to raise $100 Million for marijuana related investments. These warrants are already in the hands of Mentor Capital's original 1,500 mostly accredited investors. The call period is through June 30th, 2014.

Mentor Capital Acquires 60% of Bhang Chocolate for $39 Million
Business Wire - Tue Mar 11, 11:11AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has been selected by Bhang Chocolate Company, Inc. to provide $39 Million in equity funding for Bhang's national and international expansion and to help further extend their market-leading brand across the marijuana related sector. Mentor Capital CEO, Chet Billingsley, affirms, "By a wide margin, five time cannabis cup winner, Bhang Chocolate is recognized as the world's singular leading cannabis brand. We feel privileged to be working with the Bhang management team lead by founder Scott Van Rixel. In the explosively growing and sometimes chaotic environment accompanying marijuana legalization, they provide a bulwark of business professionalism and integrity in the delivery of Bhang's gourmet medicinal chocolates and growing infused edible selections."

WEALTHMAKERS.COM Issues Report on Mentor Capital
M2 - Mon Mar 10, 8:54AM CDT
March 10, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Mentor Capital (OTC: MNTR). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $2.54 and the projected short squeeze price target of $19.59 per share.

Mentor Capital Catches Market Makers Selling 250% of Shares
Marketwire - Tue Feb 25, 11:50AM CST
Mentor Capital, Inc. (OTC Pink: MNTR) announces that BuyIns.Net has uncovered that Shorts have sold 5.5 Million of the 2.2 Million (sic.) Mentor Capital, Inc. shares in the float and available to trade. In response to this situation, Mentor Capital Inc.'s CEO, Chet Billingsley comments, "For 2014 we retained BuyIns.Net, who monitors all stock trades for illegal short selling activity, soon after 50% of our float suspiciously traded in two hours." According to his web site, BuyIns.Net founder, Tom Ronk, entered into a business partnership with former SEC Chairman, Harvey Pitt. They spearheaded the passage of Regulation SHO that, if followed, helps safeguard public companies from these sorts of short selling issues.

BUYINS.NET Issues Mentor Capital SqueezeTrigger Report
M2 - Tue Feb 25, 2:34AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Mentor Capital (OTC: MNTR) after releasing the latest short sale data through February 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.45 million shares. Approximately 41.09% of daily trading volume is short selling. The SqueezeTrigger price for all MNTR shares shorted is $1.53. A short squeeze has just begun as shares of MNTR closed above the $1.53 SqueezeTrigger price.

Mentor Capital Acquires 51% Stake in MicroCannaBiz, LLC
Business Wire - Thu Feb 20, 12:54PM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has acquired a 51% equity interest in MicroCannaBiz, LLC, which was recently formed to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.

Mentor Capital Agrees to $2M Backing for Cannabis Advocacy Business
Business Wire - Mon Jan 27, 7:30AM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has agreed to provide $2 Million in funding for The Cannabis Advocacy Machine. Mentor Capital CEO, Chester Billingsley, explains that behind any political initiative there is a commercial enterprise in the business of developing data and statistics, directing advertisement, and maintaining proprietary software systems. The Cannabis Advocacy Machine, a division of The Machine Corporation, is providing Moneyball-like direction and support that is key to that process for the legalization of cannabis across the country. "Signing a letter of intent for 20% of The Machine Corporation under the nationally experienced leadership of the first tier team with Joe Brezny, aims to accelerate the legislative initiatives critical to the lifting of marijuana prohibition, in what may be a surprisingly profitable manner."

Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014
Business Wire - Wed Jan 22, 10:25AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cannabis Index appreciated 325% during the first three weeks of 2014. The overall positive and profitable experience for marijuana based businesses and taxing authorities alike is thought to be a key driver in this sector-wide advance.

Mentor Capital Cancer Immunotherapy Index Up 97% in 2013
Business Wire - Tue Jan 21, 10:01AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 97.4% during 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 annual period the biotech indices averaged a 54.8% gain.

Mentor Capital Says HempCon to be First Funded from New Public Cannabis Fund
Business Wire - Fri Jan 17, 12:40PM CST
Mentor Capital, Inc. (OTC Markets:MNTR) announced its first major acquisition for cannabis funding will be HempCon, Inc. That medical marijuana convention company is hosting hemp industry pioneers at the San Jose Convention Center January 17-19th. The agreement by principals and letter of intent outlines that HempCon, Inc. will receive $7.0 Million from Mentor Capital investors plus future public market appreciation for a 100% interest. Positioning HempCon to be the first to be funded by the first operating public cannabis fund of its kind should be wholly credited to savvy action by HempCon founder Edwin Kwong, who had already been approached by two other public companies, reports Mentor Capital CEO Chester Billingsley.

Mentor Capital Negotiates to Fund Eighteen Leading Cannabis Brands
Business Wire - Wed Nov 13, 9:43AM CST
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that it has entered into negotiations to fund eighteen legal cannabis related companies. These companies are variously described in writing by their fellow CEO's as the "cream of the crop," "great, " "the best... I have ever seen" and that "their Cannabis Cup awards speak for themselves." While not every one of the CEO's in negotiations will finally join Mentor Capital, the offers are generally what management has already verbally agreed to.

Mentor Capital Cancer Immunotherapy Index Up 100% in 2013
Business Wire - Wed Oct 16, 7:03AM CDT
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 101.7% during the first three quarters of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 YTD period the biotech indices averaged a 46.0% gain.

Mentor Capital, Inc. Funds Completion of 12.5% Stock Buyback
Business Wire - Thu Sep 05, 1:56PM CDT
Mentor Capital, Inc. (OTCMKTS:MNTR) has deposited funds with its broker to complete the final tranche of its multi-year stock repurchase program. In 2008, Mentor Capital, Inc. committed to the repurchase of 12.5% of its then outstanding common stock and is positioned to wrap-up that stock buy-back now.

Mentor Capital Cancer Immunotherapy Index Gains 31% During First Half of 2013
Business Wire - Fri Jul 19, 12:49PM CDT
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 30.6% during the first half of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the first half the biotech indices averaged a 34.5% gain.

Mentor Capital Cancer Immunotherapy Index Gains 32% YTD and Adds Second Generation Firms for 2013
Business Wire - Fri Mar 15, 11:51AM CDT
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that for 2013 it has added Galena Biopharma Corporation (NASDAQ:GALE), NewLink Genetics Corporation (NASDAQ:NLNK), Vical Incorporated (NASDAQ:VICL) and Inovio Pharmaceuticals, Inc. (NYSE MKT:INO) to its proprietary Cancer Immunotherapy Index. The four firms and others in the Index represent the second generation immunotherapy knowledge that has evolved since 2009 when Mentor Capital first published.

Mentor Capital Telemedicine Investee Projects $1.0 Million Profit
Business Wire - Wed Mar 13, 11:40AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that its portfolio company, Brighter Day Health, LLC, after a period of aggressive growth, reports it is ahead of budget and turning the corner to profitable operation. Brighter Day projects a before-tax profit of $1.0 Million for the next full fiscal year and $400,000 profit for the remainder of 2013. This positions the company for a planned 2015 exit seeking to match the market typical multiple of 12x-17x.

Mentor Capital Cancer Immunotherapy Index Posts 11% Annual Loss in 2012 and Adds Companies for 2013
Business Wire - Tue Feb 19, 6:55AM CST
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index declined (-10.9%) during 2012. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For 2012 the biotech indices averaged a 32.7% gain. In comparison, during the first six months of 2012, the Dow, S&P 500 and NASDAQ Composite indices appreciated 5.90%, 16.61% and 15.89%, respectively.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 97

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 302

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 158

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Blend's AWS Financial Services Competency Enhances Innovations

Updated Category News Views 152

Blend Takes a Major Stride with AWS Financial Services Competency Exciting news emerges from Blend as the company secures a crucial recognition in the cloud technology arena. They've recently achieved the prestigious AWS Financial Services Competency badge, a testament to their outstanding expertise and remarkable track record in delivering innovative, secure, and...

Continue Reading
The Upcoming Surge of Last Mile Delivery Market Growth

Updated Category News Views 289

Overview of the Last Mile Delivery Market Growth The Last Mile Delivery market is poised for significant growth in the coming years, projected to rise by USD 51.1 billion from 2025 to 2029. This increase is primarily driven by the expanding global e-commerce sector and the integration of advanced technologies, including AI, which are transforming logistical operations....

Continue Reading
Tide Rock Expands Its Precision Machining Horizons Through Acquisitions

Updated Category News Views 326

Tide Rock Expands Its Precision Machining Horizons Tide Rock has taken a significant leap forward in the field of advanced precision machining through its recent acquisitions. By acquiring Precision Waterjet & Laser, now known as Precision Advanced Machining, located in Anaheim, California, and Made in America Manufacturing based in Buda, Texas, Tide Rock is enhancing its...

Continue Reading
Novavax Revises Projections, Anticipates Robust Nuvaxovid Demand

Updated Category News Views 149

Novavax Reports Strong Second Quarter Results Recently, Novavax Inc. reported impressive sales of $239.24 million for the second quarter of 2025, marking a significant shift from $415 million during the same period in the previous year. This figure exceeded the Wall Street consensus expectations, which estimated sales at $156.29 million. Such growth highlights Novavax's...

Continue Reading
Insights into Novartis' Cosentyx and GCAptAIN Study Findings

Updated Category News Views 219

Novartis' Groundbreaking Updates on Cosentyx in GCAptAIN Study Novartis has recently provided significant updates regarding the Phase III GCAptAIN study, focusing on the efficacy of Cosentyx (secukinumab) for patients suffering from giant cell arteritis (GCA). This condition, predominantly affecting older adults, poses a risk of severe complications if not managed...

Continue Reading